Neural stem cell transplantation enhances mitochondrial biogenesis in a transgenic mouse model of Alzheimer's disease-like pathology

Neurobiology of Aging

Volumn 36, Issue 3, 2015, Pages 1282-1292

  Zhang, Wei ^a   Gu, Guo Jun ^a   Shen, Xing ^b   Zhang, Qi ^c   Wang, Gang Min ^c   Wang, Pei Jun ^a  

^a TONGJI UNIVERSITY   (China)

^b Traditional Chinese Hospital   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Cognitive function; Mitochondrial biogenesis; Neural stem cells; Transplantation

Indexed keywords

AMYLOID PRECURSOR PROTEIN; DYNAMIN I; FISSION 1; MITOCHONDRIAL DNA; MITOCHONDRIAL FUSION FACTOR MITOFUSION 1; MITOCHONDRIAL FUSION FACTOR MITOFUSION 2; MITOCHONDRIAL FUSION FACTOR OPTIC ATROPHY 1; MITOCHONDRIAL PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN COXIV; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFR 1; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; DNM1L PROTEIN, MOUSE; DYNAMIN; FIS1 PROTEIN, MOUSE; GUANOSINE TRIPHOSPHATASE; MFN1 PROTEIN, MOUSE; OPA1 PROTEIN (GTPASE), MOUSE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN REGION; CELL COUNT; CELL RENEWAL; COGNITION; COGNITIVE DEFECT; GENE EXPRESSION; HIPPOCAMPUS; IN VITRO STUDY; MITOCHONDRION; MOUSE; NERVE CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPATIAL LEARNING; SPATIAL MEMORY; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; MITOCHONDRIAL DYNAMICS; NEURAL STEM CELL; PATHOLOGY; PATHOPHYSIOLOGY; TRANSGENIC MOUSE; TRANSPLANTATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; COGNITION; DISEASE MODELS, ANIMAL; DNA, MITOCHONDRIAL; DYNAMINS; GENE EXPRESSION; GTP PHOSPHOHYDROLASES; MICE, TRANSGENIC; MITOCHONDRIAL PROTEINS; MITOCHONDRIAL TURNOVER; NEURAL STEM CELLS;

EID: 84923581409     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.10.040     Document Type: Article

References (58)

1. Atamna H., Frey W.H. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease. Mitochondrion 2007, 7:297-310.
2. Billings L.M., Oddo S., Green K.N., McGaugh J.L., LaFerla F.M. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005, 45:675-688.
3. Blennow K., de Leon M.J., Zetterberg H. Alzheimer's disease. Lancet 2006, 368:387-403.
4. Blurton-Jones M., Kitazawa M., Martinez-Coria H., Castello N.A., Muller F.J., Loring J.F., Yamasaki T.R., Poon W.W., Green K.N., LaFerla F.M. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13594-13599.
5. Cagalinec M., Safiulina D., Liiv M., Liiv J., Choubey V., Wareski P., Veksler V., Kaasik A. Principles of the mitochondrial fusion and fission cycle in neurons. J.Cell Sci. 2013, 126:2187-2197.
6. Calkins M.J., Manczak M., Mao P., Shirendeb U., Reddy P.H. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum. Mol. Genet. 2011, 20:4515-4529.
7. Caspersen C., Wang N., Yao J., Sosunov A., Chen X., Lustbader J.W., Xu H.W., Stern D., McKhann G., Yan S.D. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 2005, 19:2040-2041.
8. Chan D.C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006, 125:1241-1252.
9. Chaturvedi R.K., Adhihetty P., Shukla S., Hennessy T., Calingasan N., Yang L., Starkov A., Kiaei M., Cannella M., Sassone J., Ciammola A., Squitieri F., Beal M.F. Impaired PGC-1alpha function in muscle in Huntington's disease. Hum. Mol. Genet. 2009, 18:3048-3065.
10. Chen L., Lee H.M., Greeley G.H., Englander E.W. Accumulation of oxidatively generated DNA damage in the brain: a mechanism of neurotoxicity. Free Radic. Biol. Med. 2007, 42:385-393.
11. Chen J.X., Yan S.S. Role of mitochondrial amyloid-beta in Alzheimer's disease. J.Alzheimers Dis. 2010, 20(Suppl 2):S569-S578.
12. Cheng A., Hou Y., Mattson M.P. Mitochondria and neuroplasticity. ASN Neurol. 2010, 2:e00045.
13. Cipolat S., Martins de Brito O., Dal Zilio B., Scorrano L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:15927-15932.
14. Demars M., Hu Y.S., Gadadhar A., Lazarov O. Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice. J.Neurosci. Res. 2010, 88:2103-2117.
15. DuBoff B., Gotz J., Feany M.B. Tau promotes neurodegeneration via DRP1 mislocalization invivo. Neuron 2012, 75:618-632.
16. Ferrer I. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease. J.Bioenerg. Biomembr. 2009, 41:425-431.
17. Frezza C., Cipolat S., Martins de Brito O., Micaroni M., Beznoussenko G.V., Rudka T., Bartoli D., Polishuck R.S., Danial N.N., De Strooper B., Scorrano L. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006, 126:177-189.
18. Gillardon F., Rist W., Kussmaul L., Vogel J., Berg M., Danzer K., Kraut N., Hengerer B. Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition. Proteomics 2007, 7:605-616.
19. Gupta S., Knowlton A.A. Cytosolic heat shock protein 60, hypoxia, and apoptosis. Circulation 2002, 106:2727-2733.
20. Hardas S.S., Sultana R., Clark A.M., Beckett T.L., Szweda L.I., Murphy M.P., Butterfield D.A. Oxidative modification of lipoic acid by HNE in Alzheimer disease brain. Redox Biol. 2013, 1:80-85.
21. Hood D.A., Saleem A. Exercise-induced mitochondrial biogenesis in skeletal muscle. Nutr. Metab. Cardiovasc. Dis. 2007, 17:332-337.
22. Lai A.Y., McLaurin J. Inhibition of amyloid-beta peptide aggregation rescues the autophagic deficits in the TgCRND8 mouse model of Alzheimer disease. Biochim. Biophys. Acta 2012, 1822:1629-1637.
23. Liu X., Feng L., Yan M., Xu K., Yu Y., Zheng X. Changes in mitochondrial dynamics during amyloid beta-induced PC12 cell apoptosis. Mol. Cell Biochem. 2010, 344:277-284.
24. Ljubicic V., Joseph A.M., Saleem A., Uguccioni G., Collu-Marchese M., Lai R.Y., Nguyen L.M., Hood D.A. Transcriptional and post-transcriptional regulation of mitochondrial biogenesis in skeletal muscle: effects of exercise and aging. Biochim. Biophys. Acta 2010, 1800:223-234.
25. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:7951-7955.
26. Lu P., Jones L.L., Snyder E.Y., Tuszynski M.H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol. 2003, 181:115-129.
27. Lu B., Wang K.H., Nose A. Molecular mechanisms underlying neural circuit formation. Curr. Opin. Neurobiol. 2009, 19:162-167.
28. Mai S., Klinkenberg M., Auburger G., Bereiter-Hahn J., Jendrach M. Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK1. J.Cell Sci. 2010, 123:917-926.
29. Manczak M., Anekonda T.S., Henson E., Park B.S., Quinn J., Reddy P.H. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 2006, 15:1437-1449.
30. Manczak M., Mao P., Calkins M.J., Cornea A., Reddy A.P., Murphy M.P., Szeto H.H., Park B., Reddy P.H. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J.Alzheimers Dis. 2010, 20(Suppl 2):S609-S631.
31. Marjanska M., Curran G.L., Wengenack T.M., Henry P.G., Bliss R.L., Poduslo J.F., Jack C.R., Ugurbil K., Garwood M. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11906-11910.
32. Matsubara E., Bryant-Thomas T., Pacheco Quinto J., Henry T.L., Poeggeler B., Herbert D., Cruz-Sanchez F., Chyan Y.J., Smith M.A., Perry G., Shoji M., Abe K., Leone A., Grundke-Ikbal I., Wilson G.L., Ghiso J., Williams C., Refolo L.M., Pappolla M.A., Chain D.G., Neria E. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J.Neurochem. 2003, 85:1101-1108.
33. Mattson M.P. Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease. Trends Neurosci. 1997, 20:373-375.
34. McInnes J. Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration. Transl. Neurodegener. 2013, 2:12.
35. Murphy M.P., Smith R.A. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu. Rev. Pharmacol. Toxicol. 2007, 47:629-656.
36. Onyango I.G., Ahn J.Y., Tuttle J.B., Bennett J.P., Swerdlow R.H. Nerve growth factor attenuates oxidant-induced beta-amyloid neurotoxicity in sporadic Alzheimer's disease cybrids. J.Neurochem. 2010, 114:1605-1618.
37. Park J., Kim Y., Choi S., Koh H., Lee S.H., Kim J.M., Chung J. Drosophila Porin/VDAC affects mitochondrial morphology. PLoS One 2010, 5:e13151.
38. Perez-Gracia E., Torrejon-Escribano B., Ferrer I. Dystrophic neurites of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase. Acta Neuropathol. 2008, 116:261-268.
39. Qin W., Haroutunian V., Katsel P., Cardozo C.P., Ho L., Buxbaum J.D., Pasinetti G.M. PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch. Neurol. 2009, 66:352-361.
40. Ramirez C.M., Gonzalez M., Diaz M., Alonso R., Ferrer I., Santpere G., Puig B., Meyer G., Marin R. VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimer's disease. Mol. Cell Neurosci. 2009, 42:172-183.
41. Reddy P.H., Tripathi R., Troung Q., Tirumala K., Reddy T.P., Anekonda V., Shirendeb U.P., Calkins M.J., Reddy A.P., Mao P., Manczak M. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim. Biophys. Acta 2012, 1822:639-649.
42. Rohas L.M., St-Pierre J., Uldry M., Jager S., Handschin C., Spiegelman B.M. Afundamental system of cellular energy homeostasis regulated by PGC-1alpha. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:7933-7938.
43. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
44. Stackman R.W., Eckenstein F., Frei B., Kulhanek D., Nowlin J., Quinn J.F. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp. Neurol. 2003, 184:510-520.
45. Steele J.W., Gandy S. Latrepirdine (Dimebon(R)), a potential Alzheimer therapeutic, regulates autophagy and neuropathology in an Alzheimer mouse model. Autophagy 2013, 9:617-618.
46. Suen D.F., Norris K.L., Youle R.J. Mitochondrial dynamics and apoptosis. Genes Dev. 2008, 22:1577-1590.
47. Swerdlow R.H. Pathogenesis of Alzheimer's disease. Clin. Interv. Aging 2007, 2:347-359.
48. Takuma K., Yao J., Huang J., Xu H., Chen X., Luddy J., Trillat A.C., Stern D.M., Arancio O., Yan S.S. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J. 2005, 19:597-598.
49. Thinnes F.P. Opening cell membrane-standing type-1 VDAC/porin channels by trivalent aluminium-a factor in amyotrophic lateral sclerosis and Alzheimer's disease?. Mol. Genet. Metab. 2010, 101:299-300.
50. Tranah G.J., Yokoyama J.S., Katzman S.M., Nalls M.A., Newman A.B., Harris T.B., Cesari M., Manini T.M., Schork N.J., Cummings S.R., Liu Y., Yaffe K., Health A., Body Composition S. Mitochondrial DNA sequence associations with dementia and amyloid-beta in elderly African Americans. Neurobiol. Aging 2014, 35:442.e1-442.e8.
51. Uo T., Dworzak J., Kinoshita C., Inman D.M., Kinoshita Y., Horner P.J., Morrison R.S. Drp1 levels constitutively regulate mitochondrial dynamics and cell survival in cortical neurons. Exp. Neurol. 2009, 218:274-285.
52. Walls K.C., Coskun P., Gallegos-Perez J.L., Zadourian N., Freude K., Rasool S., Blurton-Jones M., Green K.N., LaFerla F.M. Swedish Alzheimer mutation induces mitochondrial dysfunction mediated by HSP60 mislocalization of amyloid precursor protein (APP) and beta-amyloid. J.Biol. Chem. 2012, 287:30317-30327.
53. Wareski P., Vaarmann A., Choubey V., Safiulina D., Liiv J., Kuum M., Kaasik A. PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons. J.Biol. Chem. 2009, 284:21379-21385.
54. Weydt P., Pineda V.V., Torrence A.E., Libby R.T., Satterfield T.F., Lazarowski E.R., Gilbert M.L., Morton G.J., Bammler T.K., Strand A.D., Cui L., Beyer R.P., Easley C.N., Smith A.C., Krainc D., Luquet S., Sweet I.R., Schwartz M.W., La Spada A.R. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab. 2006, 4:349-362.
55. Xie H., Guan J., Borrelli L.A., Xu J., Serrano-Pozo A., Bacskai B.J. Mitochondrial alterations near amyloid plaques in an Alzheimer's disease mouse model. J.Neurosci. 2013, 33:17042-17051.
56. Yang D.S., Stavrides P., Mohan P.S., Kaushik S., Kumar A., Ohno M., Schmidt S.D., Wesson D., Bandyopadhyay U., Jiang Y., Pawlik M., Peterhoff C.M., Yang A.J., Wilson D.A., St George-Hyslop P., Westaway D., Mathews P.M., Levy E., Cuervo A.M., Nixon R.A. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain 2011, 134:258-277.
57. Yao J., Irwin R.W., Zhao L., Nilsen J., Hamilton R.T., Brinton R.D. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14670-14675.
58. Zhang W., Wang G.M., Wang P.J., Zhang Q., Sha S.H. Effects of neural stem cells on synaptic proteins and memory in a mouse model of Alzheimer's disease. J.Neurosci. Res. 2014, 92:185-194.